imec.xpand led a $50m Series B round in INBRAIN Neuroelectronics.

imec.xpand, an independently managed fund that focuses on hardware based nanotechnology innovations, led a $50m Series B round in INBRAIN Neuroelectronics, brain-computer interface therapeutics company, with participation from EIC Fund, ICO Next Tech, CDTI, Avançsa, Asabys Partners, Aliath Bioventures and Vsquared. “We’re shaping the future of brain-computer interface therapeutics. This funding empowers us to advance our AI-driven graphene neurotechnology, which has already shown great results versus current commercial neuromodulation technology. We are excited to have the support of a top-tier syndicate as we work to bring this technology to patients in need of more precise, personalized treatments,” Carolina Aguilar, INBRAIN Neuroelectronics CEO and Co-Founder.